Document Detail


Viral hepatitis C.
MedLine Citation:
PMID:  10825999     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Identification of a cDNA clone and the genome of hepatitis C virus in 1988-1989 allowed the development of clinical tests that are now used to detect and quantify hepatitis C virus. This has largely eliminated post-transfusion hepatitis C virus infection; however, the overall incidence of chronic hepatitis C and its complications has greatly increased because of its transmission by other means, lack of a protective vaccine, and inadequate virucidal therapy. Drug abuse is the most common cause of hepatitis C; an etiologic mechanism, however, remains unknown in one third of patients referred to the New Jersey Medical School Liver Center. Response to treatment depends on the viral subtype, immune reactivity of the host, and hepatic pathologic alterations. Many patients with hepatitis C improve or are cured by administering an interferon with or without ribavirin; patients refractory to these measures exhibit persistent elevation of serum cytokines and progressive liver disease. New measures, including protease inhibitors and adjunct immunotherapy, should increase effectiveness of therapy, diminishing hepatitis C virus-induced cirrhosis and hepatocellular cancer. Populations, including the underserved, who harbor and transmit hepatitis C virus require special assistance. This is best achieved by community support groups organized through medical schools, physician associations, and churches to help prevent, detect, and treat chronic hepatitis C.
Authors:
C B Leevy; K G Zierer; C M Leevy
Related Documents :
23342569 - Idiopathic ulcers as an oral manifestation in pediatric patients with aids: multidiscip...
7425529 - Histology in chronic hepatitis.
171949 - Viral hepatitis: a pathologic spectrum.
23970589 - Testicular and kidney masses in a hiv-infected man.
8855439 - Association between reactive oxygen species and disease activity in chronic hepatitis c.
6855199 - Ethanol, hepatocellular organelles, and microtubules. a morphometric study in vivo and ...
17241379 - Impact of human immunodeficiency virus infection in patients infected with the hepatiti...
20929279 - Nucleoside reverse transcriptase inhibitor toxicity and mitochondrial dna.
20920109 - Markers of hepatitis b virus infection and immunity in victoria, australia, 1995 to 2005.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Journal of the Association for Academic Minority Physicians : the official publication of the Association for Academic Minority Physicians     Volume:  9     ISSN:  1048-9886     ISO Abbreviation:  J Assoc Acad Minor Phys     Publication Date:  1998  
Date Detail:
Created Date:  2000-06-08     Completed Date:  2000-06-08     Revised Date:  2008-11-21    
Medline Journal Info:
Nlm Unique ID:  9113765     Medline TA:  J Assoc Acad Minor Phys     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  59-64     Citation Subset:  IM; X    
Affiliation:
UMDNJ-New Jersey Medical School Liver Center, Newark 07103, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Acquired Immunodeficiency Syndrome / complications
Genetic Variation
Hepacivirus / genetics,  immunology
Hepatitis C* / diagnosis,  genetics,  therapy
Interferons / therapeutic use
Chemical
Reg. No./Substance:
9008-11-1/Interferons

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Total synthesis of (+)-thiazinotrienomycin E.
Next Document:  Post-extubation stridor: risk factors and outcome.